-
1
-
-
33749133430
-
Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase
-
Ramirez A, Heimbach A, Grundemann J, Stiller B, Hampshire D, Cid LP, Goebel I, Mubaidin AF, Wriekat AL, Roeper J, Al-Din A, Hillmer AM, Karsak M, Liss B, Woods CG, Behrens MI, Kubisch C: Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet 2006, 38: 1184-1191. 10.1038/ng1884
-
(2006)
Nat Genet
, vol.38
, pp. 1184-1191
-
-
Ramirez, A.1
Heimbach, A.2
Grundemann, J.3
Stiller, B.4
Hampshire, D.5
Cid, L.P.6
Goebel, I.7
Mubaidin, A.F.8
Wriekat, A.L.9
Roeper, J.10
Al-Din, A.11
Hillmer, A.M.12
Karsak, M.13
Liss, B.14
Woods, C.G.15
Behrens, M.I.16
Kubisch, C.17
-
2
-
-
61349147706
-
Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity
-
Gitler AD, Chesi A, Geddie ML, Strathearn KE, Hamamichi S, Hill KJ, Caldwell KA, Caldwell GA, Cooper AA, Rochet JC, Lindquist S: Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat Genet 2009, 41: 308-315. 10.1038/ng.300
-
(2009)
Nat Genet
, vol.41
, pp. 308-315
-
-
Gitler, A.D.1
Chesi, A.2
Geddie, M.L.3
Strathearn, K.E.4
Hamamichi, S.5
Hill, K.J.6
Caldwell, K.A.7
Caldwell, G.A.8
Cooper, A.A.9
Rochet, J.C.10
Lindquist, S.11
-
3
-
-
79960836347
-
Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism
-
Park JS, Mehta P, Cooper AA, Veivers D, Heimbach A, Stiller B, Kubisch C, Fung VS, Krainc D, Mackay-Sim A, Sue CM: Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism. Hum Mutat 2011, 32: 956-964. 10.1002/humu.21527
-
(2011)
Hum Mutat
, vol.32
, pp. 956-964
-
-
Park, J.S.1
Mehta, P.2
Cooper, A.A.3
Veivers, D.4
Heimbach, A.5
Stiller, B.6
Kubisch, C.7
Fung, V.S.8
Krainc, D.9
Mackay-Sim, A.10
Sue, C.M.11
-
4
-
-
84859246513
-
PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity
-
Ramonet D, Podhajska A, Stafa K, Sonnay S, Trancikova A, Tsika E, Pletnikova O, Troncoso JC, Glauser L, Moore DJ: PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity. Hum Mol Genet 2012, 21: 1725-1743. 10.1093/hmg/ddr606
-
(2012)
Hum Mol Genet
, vol.21
, pp. 1725-1743
-
-
Ramonet, D.1
Podhajska, A.2
Stafa, K.3
Sonnay, S.4
Trancikova, A.5
Tsika, E.6
Pletnikova, O.7
Troncoso, J.C.8
Glauser, L.9
Moore, D.J.10
-
5
-
-
84866529985
-
Lysosomal dysfunction in Parkinson disease: ATP13A2 gets into the groove
-
Dehay B, Martinez-Vicente M, Ramirez A, Perier C, Klein C, Vila M, Bezard E: Lysosomal dysfunction in Parkinson disease: ATP13A2 gets into the groove. Autophagy 2012, 8: 1389-1391.
-
(2012)
Autophagy
, vol.8
, pp. 1389-1391
-
-
Dehay, B.1
Martinez-Vicente, M.2
Ramirez, A.3
Perier, C.4
Klein, C.5
Vila, M.6
Bezard, E.7
-
6
-
-
84856578855
-
ATP13A2 regulates mitochondrial bioenergetics through macroautophagy
-
Gusdon AM, Zhu J, Van Houten B, Chu CT: ATP13A2 regulates mitochondrial bioenergetics through macroautophagy. Neurobiol Dis 2011, 45: 962-972.
-
(2011)
Neurobiol Dis
, vol.45
, pp. 962-972
-
-
Gusdon, A.M.1
Zhu, J.2
Van Houten, B.3
Chu, C.T.4
-
7
-
-
84864877323
-
Lysosomal dysfunction in neurodegeneration: the role of ATP13A2/PARK9
-
Usenovic M, Krainc D: Lysosomal dysfunction in neurodegeneration: the role of ATP13A2/PARK9. Autophagy 2012, 8: 987-988.
-
(2012)
Autophagy
, vol.8
, pp. 987-988
-
-
Usenovic, M.1
Krainc, D.2
-
8
-
-
84862189804
-
Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration
-
Dehay B, Ramirez A, Martinez-Vicente M, Perier C, Canron MH, Doudnikoff E, Vital A, Vila M, Klein C, Bezard E: Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration. Proc Natl Acad Sci U S A 2012, 109: 9611-9616. 10.1073/pnas.1112368109
-
(2012)
Proc Natl Acad Sci U S A
, vol.109
, pp. 9611-9616
-
-
Dehay, B.1
Ramirez, A.2
Martinez-Vicente, M.3
Perier, C.4
Canron, M.H.5
Doudnikoff, E.6
Vital, A.7
Vila, M.8
Klein, C.9
Bezard, E.10
-
9
-
-
0030681215
-
Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease
-
The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease: Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging 1997, 18: S1-S2.
-
(1997)
Neurobiol Aging
, vol.18
, pp. S1-S2
-
-
-
10
-
-
79958169700
-
Changes in the solubility and phosphorylation of alpha-synuclein over the course of Parkinson's disease
-
Zhou J, Broe M, Huang Y, Anderson JP, Gai WP, Milward EA, Porritt M, Howells D, Hughes AJ, Wang X, Halliday GM: Changes in the solubility and phosphorylation of alpha-synuclein over the course of Parkinson's disease. Acta Neuropathol 2011, 121: 695-704. 10.1007/s00401-011-0815-1
-
(2011)
Acta Neuropathol
, vol.121
, pp. 695-704
-
-
Zhou, J.1
Broe, M.2
Huang, Y.3
Anderson, J.P.4
Gai, W.P.5
Milward, E.A.6
Porritt, M.7
Howells, D.8
Hughes, A.J.9
Wang, X.10
Halliday, G.M.11
-
11
-
-
84858403126
-
Deficiency of ATP13A2 Leads to Lysosomal Dysfunction, alpha-Synuclein Accumulation, and Neurotoxicity
-
Usenovic M, Tresse E, Mazzulli JR, Taylor JP, Krainc D: Deficiency of ATP13A2 Leads to Lysosomal Dysfunction, alpha-Synuclein Accumulation, and Neurotoxicity. J Neurosci 2012, 32: 4240-4246. 10.1523/JNEUROSCI.5575-11.2012
-
(2012)
J Neurosci
, vol.32
, pp. 4240-4246
-
-
Usenovic, M.1
Tresse, E.2
Mazzulli, J.R.3
Taylor, J.P.4
Krainc, D.5
-
12
-
-
84858785513
-
The Role of the Parkinson's Disease Gene PARK9 in Essential Cellular Pathways and the Manganese Homeostasis Network in Yeast
-
Chesi A, Kilaru A, Fang X, Cooper AA, Gitler AD: The Role of the Parkinson's Disease Gene PARK9 in Essential Cellular Pathways and the Manganese Homeostasis Network in Yeast. PLoS One 2012, 7: e34178. 10.1371/journal.pone.0034178
-
(2012)
PLoS One
, vol.7
-
-
Chesi, A.1
Kilaru, A.2
Fang, X.3
Cooper, A.A.4
Gitler, A.D.5
-
13
-
-
84865064424
-
Identification of novel ATP13A2 interactors and their role in alpha-synuclein misfolding and toxicity
-
Usenovic M, Knight AL, Ray A, Wong V, Brown KR, Caldwell GA, Caldwell KA, Stagljar I, Krainc D: Identification of novel ATP13A2 interactors and their role in alpha-synuclein misfolding and toxicity. Hum Mol Genet 2012, 21: 3785-3794. 10.1093/hmg/dds206
-
(2012)
Hum Mol Genet
, vol.21
, pp. 3785-3794
-
-
Usenovic, M.1
Knight, A.L.2
Ray, A.3
Wong, V.4
Brown, K.R.5
Caldwell, G.A.6
Caldwell, K.A.7
Stagljar, I.8
Krainc, D.9
-
14
-
-
0037333666
-
Staging of brain pathology related to sporadic Parkinson's disease
-
Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E: Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003, 24: 197-211. 10.1016/S0197-4580(02)00065-9
-
(2003)
Neurobiol Aging
, vol.24
, pp. 197-211
-
-
Braak, H.1
Del Tredici, K.2
Rub, U.3
de Vos, R.A.4
Jansen Steur, E.N.5
Braak, E.6
-
15
-
-
71849092190
-
Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria
-
Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, Halliday GM, Hardy J, Leverenz JB, Del Tredici K, Wszolek ZK, Litvan I: Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. Lancet Neurol 2009, 8: 1150-1157. 10.1016/S1474-4422(09)70238-8
-
(2009)
Lancet Neurol
, vol.8
, pp. 1150-1157
-
-
Dickson, D.W.1
Braak, H.2
Duda, J.E.3
Duyckaerts, C.4
Gasser, T.5
Halliday, G.M.6
Hardy, J.7
Leverenz, J.B.8
Del Tredici, K.9
Wszolek, Z.K.10
Litvan, I.11
-
16
-
-
0031438475
-
Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type
-
Morris JC: Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr 1997,9(Suppl 1):173-176.
-
(1997)
Int Psychogeriatr
, vol.9
, pp. 173-176
-
-
Morris, J.C.1
|